- Info
- Insider Trading
- Financials
- Holders: ENGN, ENGNW
enGene Therapeutics Inc. - *W EXP 10/31/202 (ENGNW)
CUSIP: 29286M113
Q4 2024 13F Holders as of 31 Dec 2024
- Type / Class
- Equity / *W EXP 10/31/202
- Total 13F shares
- 4,762,265
- Share change
- -473,569
- Total reported value
- $4,024,339
- Price per share
- $0.84
- Number of holders
- 15
- Value change
- -$399,359
- Number of buys
- 1
- Number of sells
- 3
Quarterly Holders Quick Answers
What is CUSIP 29286M113?
CUSIP 29286M113 identifies ENGNW - enGene Therapeutics Inc. - *W EXP 10/31/202 in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 29286M113:
Top shareholders of ENGNW - enGene Therapeutics Inc. - *W EXP 10/31/202 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FCPM III SERVICES B.V. |
13F
|
Company |
—
mixed-class rows
|
11,556,099
mixed-class rows
|
$63,318,587 | — | 30 Sep 2024 | |
| Forbion Growth Opportunities Fund I Cooperatief U.A. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
6,798,362
|
$60,505,422 | — | 30 Oct 2024 | |
| Fonds de solidarite des travailleurs et des travailleuses du Quebec |
3/4/5
13D/G
|
10%+ Owner |
4.5%
from 13D/G
|
3,036,153
|
$45,542,295 | — | 18 Apr 2024 | |
| Lumira Capital Investment Management Inc. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
3,849,299
|
$38,492,990 | — | 20 Feb 2024 | |
| VR Adviser, LLC |
13F
|
Company |
5.3%
|
3,565,841
|
$23,534,551 | — | 30 Sep 2024 | |
| Blue Owl Capital Holdings LP |
13F
|
Company |
—
mixed-class rows
|
3,570,146
mixed-class rows
|
$20,917,622 | — | 30 Sep 2024 | |
| Deep Track Capital, LP |
13F
|
Company |
3.9%
|
2,607,633
|
$17,210,378 | — | 30 Sep 2024 | |
| BVF INC/IL |
13F
|
Company |
—
mixed-class rows
|
3,196,439
mixed-class rows
|
$15,660,530 | — | 30 Sep 2024 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
3.5%
|
2,329,768
|
$15,376,469 | — | 30 Sep 2024 | |
| Kynam Capital Management, LP |
13F
|
Company |
2.6%
|
1,736,227
|
$11,459,098 | — | 30 Sep 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
1.8%
|
1,189,952
|
$9,186,429 | — | 30 Sep 2024 | |
| Omega Fund Management, LLC |
13F
|
Company |
—
mixed-class rows
|
1,397,859
mixed-class rows
|
$7,779,110 | — | 30 Sep 2024 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
1.5%
|
1,000,000
|
$6,625,000 | — | 30 Sep 2024 | |
| Cormorant Asset Management, LP |
13F
|
Company |
1.5%
|
1,000,000
|
$6,600,000 | — | 30 Sep 2024 | |
| Adage Capital Management, L.P. |
13D/G
|
— |
3%
|
1,528,768
|
$6,115,072 | $0 | 31 Dec 2024 | |
| Logos Global Management LP |
13F
|
Company |
1.2%
|
800,000
|
$5,280,000 | — | 30 Sep 2024 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
1.2%
|
800,000
|
$5,280,000 | — | 30 Sep 2024 | |
| SR ONE CAPITAL MANAGEMENT, LP |
13F
|
Company |
1.1%
|
747,750
|
$4,935,150 | — | 30 Sep 2024 | |
| Boxer Capital, LLC |
13F
|
Company |
1.1%
|
727,900
|
$4,804,140 | — | 30 Sep 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
1%
|
681,545
|
$4,498,196 | — | 30 Sep 2024 | |
| Vivo Capital, LLC |
13F
|
Company |
1%
|
678,705
|
$4,479,453 | — | 30 Sep 2024 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.99%
|
663,000
|
$4,375,800 | — | 30 Sep 2024 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.46%
|
306,034
|
$2,019,824 | — | 30 Sep 2024 | |
| Ghost Tree Capital, LLC |
13F
|
Company |
0.24%
|
160,898
|
$1,061,927 | — | 30 Sep 2024 | |
| SECTORAL ASSET MANAGEMENT INC |
13F
|
Company |
0.14%
|
94,219
|
$621,845 | — | 30 Sep 2024 | |
| Saba Capital Management, L.P. |
13F
|
Company |
—
class O/S missing
|
192,334
|
$274,076 | — | 30 Sep 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.06%
|
39,621
|
$261,499 | — | 30 Sep 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.05%
|
34,416
|
$227,146 | — | 30 Sep 2024 | |
| Calamos Advisors LLC |
13F
|
Company |
—
class O/S missing
|
150,000
|
$213,758 | — | 30 Sep 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
—
class O/S missing
|
104,622
|
$209,244 | — | 30 Sep 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.04%
|
27,516
|
$181,605 | — | 30 Sep 2024 | |
| TENOR CAPITAL MANAGEMENT Co., L.P. |
13F
|
Company |
—
class O/S missing
|
55,243
|
$116,010 | — | 30 Sep 2024 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.02%
|
13,262
|
$87,529 | — | 30 Sep 2024 | |
| WHITEBOX ADVISORS LLC |
13F
|
Company |
—
class O/S missing
|
33,333
|
$69,999 | — | 30 Sep 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
8,193
|
$54,074 | — | 30 Sep 2024 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.01%
|
7,915
|
$52,000 | — | 30 Sep 2024 | |
| WOLVERINE ASSET MANAGEMENT LLC |
13F
|
Company |
0.01%
|
5,574
|
$36,788 | — | 30 Sep 2024 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
—
class O/S missing
|
23,570
|
$33,588 | — | 30 Sep 2024 | |
| CSS LLC/IL |
13F
|
Company |
—
class O/S missing
|
16,895
|
$32,945 | — | 30 Sep 2024 | |
| ADAR1 Capital Management, LLC |
13F
|
Company |
0%
|
1,970
|
$13,002 | — | 30 Sep 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
1,138
|
$7,511 | — | 30 Sep 2024 | |
| UBS Group AG |
13F
|
Company |
—
class O/S missing
|
3,208
|
$2,759 | — | 30 Sep 2024 | |
| CLEAR STREET LLC |
13F
|
Company |
—
class O/S missing
|
200
|
$420 | — | 30 Sep 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
—
class O/S missing
|
200
|
$172 | — | 30 Sep 2024 | |
| Forbion Growth Sponsor FEAC I B.V. |
3/4/5
|
10%+ Owner |
—
mixed-class rows
|
5,502,338
mixed-class rows
|
— | — | 31 Oct 2023 | |
| Forbion Capital Fund III Cooperatief U.A. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
2,894,735
|
— | — | 31 Oct 2023 | |
| Jason David Hanson |
3/4/5
|
Chief Executive Officer, Director |
—
class O/S missing
|
512,826
|
— | — | 31 Oct 2023 | |
| Richard P. Bryce |
3/4/5
|
Chief Medical Officer |
—
class O/S missing
|
153,000
|
— | — | 30 Nov 2023 | |
| James C. Sullivan |
3/4/5
|
Chief Scientific Officer |
—
class O/S missing
|
118,509
|
— | — | 31 Oct 2023 | |
| BVF PARTNERS L P/IL |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
104,257
|
— | — | 31 Oct 2023 |
Institutional Holders of enGene Therapeutics Inc. - *W EXP 10/31/202 (ENGNW) as of Q4 2024
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2024 vs Q3 2024 Across Filers
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 Value $ | Q4 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.